We examined whether patients with atrial fibrillation (AF) have alterations in atrial inositol 1,4,5 trisphosphate receptors (IP3 receptors). BACKGROUND Abnormal intracellular Ca 2ϩ homeostasis occurs in chronic AF. The intracellular Ca 2ϩ concentration is regulated by ryanodine and IP3 receptors. We recently reported alterations in ryanodine receptors in atrial tissue from patients in chronic AF.
Atrial fibrillation (AF) is the most frequently encountered arrhythmia in the clinical setting. The main electrophysiological mechanism underlying AF appears to be a progressive decrease in atrial refractoriness, a phenomenon that has been termed "electrical remodeling" (1) . Although this phenomenon is thought to be of importance in the selfperpetuation of AF and although cytosolic Ca 2ϩ abnormalities are an important mediator of sustained AF, the cellular and molecular mechanisms initiating or maintaining AF remain unclear. Recently, we reported that in the atrial tissue of patients with chronic AF, there are alterations in ryanodine receptors (sarcoplasmic reticulum [SR] Ca 2ϩ regulatory proteins), which play an important role in regulating the intracellular Ca 2ϩ concentration in cardiac muscle (2) . Two forms of intracellular Ca 2ϩ release channels serve to regulate the intracellular Ca 2ϩ concentration: the ryanodine receptor (RyR) and the inositol 1,4,5 trisphosphate (IP3) receptor. Recently, an IP3 receptor was detected in both intracellular and plasma membrane fractions of canine pancreatic homogenates (3) and also in cardiac myocytes (4) , in which it was restricted to the region of the intercalated discs (5) . The demonstration that both forms of Ca 2ϩ release channels are expressed in cardiac myocytes raises the possibility that a complex feedback mechanism may exist involving interactions between IP3 receptor and RyR Ca 2ϩ pools. Moreover, Kijima et al. (5) suggested that a possible role of the cardiac IP3 receptor may be to mediate Ca 2ϩ entry or to modulate intercellular communication via junctions.
The purpose of this study was to determine whether patients with chronic AF have alterations in the IP3 receptor in their atrial tissue. We studied the expression levels of IP3 receptor protein and messenger RNA (mRNA) in the right atrium after its removal during cardiac surgery from patients with chronic AF and from others with a normal sinus rhythm (NSR). disease (MVD) in whom AF had been sustained for more than two years, and 2) 5 patients with MVD who had NSR; tissue was obtained during cardiac surgery for MVD in all 18 patients. Control material (right atrial tissue from eight patients without MVD who had NSR) was obtained during coronary artery bypass surgery. All patients were evaluated by the Second Department of Internal Medicine, Yamaguchi University School of Medicine, and they underwent surgery at the Yamaguchi University Hospital. Informed consent was obtained from each patient. The protocols were in accord with guidelines laid down by the Institutional Review Board, Yamaguchi University Hospital. Demographic data (age, gender, diagnosis and hemodynamic data) are shown in Table 1 . In addition to their usual medication, all patients received preoperative sedation and perioperative anesthesia. Hemodynamic and echocardiographic data were obtained by reviewing data from preoperative cardiac catheterizations and echocardiograms. Myocardial tissue samples. Right atrial appendages were frozen immediately and stored at Ϫ80°C until needed. They were used to prepare a membrane fraction for a Western blotting assay and to produce RNA for reverse transcription polymerase chain reaction (RT-PCR) amplification. Immunoblot analysis was performed as previously described (5) with some modifications. Atrial membrane protein (40 g protein/lane) was electrophoresed on 4% SDSpolyacrylamide gels using a Laemmli buffer system (8) . The proteins in the gel were transferred to a protran nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany). The membranes were then treated with 5% nonfat dry milk in phosphate-buffer, incubated with a polyclonal anti-IP3 receptor type-1 antibody (Affinity Bioreagents, Inc., Golden, CO) (1:1000 dilution) solution and incubated further with peroxidase-conjugated secondary antibody (1: 1000 dilution). The amount of protein recognized by the antibodies was quantified by means of an ECL™ immunoblotting detection system (Amersham Pharmacia Biotech, Buckinghamshire, England), with the membrane being exposed to X-ray film. Quantitative densitometry of immunoblots was performed using a microcomputer-imaging device (AE-6900M, Atto, Tokyo, Japan). The relative activity associated with cardiac IP3 receptor protein in each sample was calculated by dividing the activity associated with the IP3 receptor protein products by the activity associated with the control (canine cerebellar IP3 receptor protein [5 g]). RNA preparation. Total cellular RNA was isolated from each frozen tissue sample (approximately 50 mg) by the method of acid guanidinium thiocyanate/phenol/ chloroform extraction (9) , then stored at Ϫ80°C.
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Complementary DNA (cDNA) was prepared using a Takara RNA PCR Kit (Takara, Tokyo, Japan), as previously described (2) in a buffer containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 5 mM MgCl 2 and 1 mM each of dCTP, dGTP, dTTP and dATP, with 20 U of recombinant ribonuclease inhibitor, 2.5 M random 9 mers, 1.3 g of total RNA, 5 U of avian myeloblastosis virus reverse transcriptase, all in a volume of 20 l. This reaction mixture was incubated for 10 min at 30°C followed by 30 min at 42°C to initiate the synthesis of the cDNAs. Reverse transcriptase was inactivated at 99°C for 5 min, and this mixture was then used for the amplification of specific cDNAs by polymerase chain reaction (PCR). The PCR was performed as follows: to 20 l of the reverse transcription reaction mixture was added 2 l of 0.1 M forward primer, 2 l of 0.1 M reverse primer, 8 l of 10 ϫ amplification buffer (100 mM Tris-HCl, pH 8.3, 500 mM KCl), 12 l of 25 mM MgCl 2 , 55 l of H 2 O, 0.5 l of (␣-32 P) dCTP (Amersham Pharmacia Biotech, Buckinghamshire, England) and 0.5 l (2.5 U/100 l) of Taq polymerase. The primers for the amplification of the IP3 receptor (type 1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed from published sequences. For the IP3 receptor, they were based on human sequences (10): at positions 5162 to 5184 (sense primer, 5Ј-GGT TTC ATT TGC AAG TTA ATA AAG-3Ј) and 5543 to 5566 (antisense primer, 5Ј-AAT GCT TTC ATG GAA CAC TCG GTC-3Ј) (predicted length of the PCR product, 405 base pair [bp] ). For GAPDH they were based on human sequences (11): at positions 102 to 125 (sense primer, 5Ј-CTT CAT TGA CCT CAA CTA CAT GGT-3Ј) and 805 to 828 (antisense primer, 5Ј-CTC AGT GTA GCC CAG GAT GCC CTT-3Ј) (predicted length of the PCR product, 726 bp). Next, 100 l of reaction mixture was overlaid with 20 l mineral oil, and cycling was performed 24 times by means of a thermal cycler (Perkin Elmer/Cetus, San Diego, California) using the following parameters: denaturation at 94°C for 1 min, annealing at 60°C for 1 min, extension at 72°C for 2 min, followed by a final incubation at 72°C for 7 min. Sequencing of the cardiac IP3 receptor cDNA. Heart total RNA was reverse transcribed into single strand cDNA and amplified under the same conditions as above. The amplified products were separated on a 1% agarose gel, then isolated from the gel using an Easytrap Ver.2 Kit (Takara, Tokyo, Japan). Nucleotide sequencing was performed by Sanger's method (12) using a DNA Sequencer ABI PRISM 377 XL (PE Applied Biosystem, Foster City, California). Quantitation of PCR products. The optimal number of amplification cycles needed to allow quantitation of cardiac IP3 receptor and GAPDH gene PCR products was determined. The PCR products for each cycle were subjected to 5% polyacrylamide gel electrophoresis and autoradiography, and the associated radioactivity was measured using an imaging analyzer (model BAS-2000; Fuji Photo Film Co., Tokyo, Japan). The optimal number of cycles was found to be 24 for both the cardiac IP3 receptor and GAPDH. Assessment of expression of cardiac IP3 receptor mRNA. The relative radioactivity associated with cardiac IP3 receptor PCR products in each sample was calculated by dividing the radioactivity associated with the IP3 receptor PCR products by the radioactivity associated with the GAPDH gene product (internal control; amplified simultaneously). Each level of RT-PCR product was obtained as the average of duplicate data. We used GAPDH as an internal control because the densitometric scores for the mRNAs did not differ between the groups of patients. Furthermore, this
Yamada et al. March 15, 2001 March 15, :1111 IP3 Receptors in the Chronically Fibrillating Atrium enzyme of the glycolytic pathway is constitutively expressed in most tissues and is the most widely accepted internal control in the molecular biology literature (13) . Light microscope immunohistochemistry. For immunostaining of the IP3 receptor, frozen tissue was allowed to equilibrate to cryostat temperature (Ϫ30°C) and was embedded in O.C.T. Compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan). Then, 4 m sections were cut, mounted on slides and dried at room temperature for 6 h. Immunostaining was performed using the avidinbiotinylated peroxidase complex. The sections were pretreated with 3% H 2 O 2 in absolute methanol to quench endogenous peroxidase activity. Endogenous avidin and biotin were blocked according to the manufacturer's recommendations (Dako LSAB Kit, Dako Co., Carpinteria, California). After equilibration in phosphate-buffered saline, the sections were blocked with 5% bovine serum albumin. Anti-IP3 receptor antibody (Affinity Bioreagents, Inc., Golden, CO) (1:50) was applied to alternate serial sections, and these were then incubated for 12 h at room temperature. After washing, the sections were incubated in biotinylated goat anti-rabbit IgG for 1 h. After three more washes, the sections were incubated with the avidin-biotin complex from a standard peroxidase kit (Dako LSAB Kit, Dako Co., Carpinteria, California). Statistical analysis. All data are presented as mean Ϯ SD.
Comparisons between data were made by one-way analysis of variance followed by Fisher's exact test. Differences were taken to be significant at p Ͻ 0.05.
RESULTS
Clinical characteristics and hemodynamic data. The preoperative hemodynamic, echocardiographic and clinical data for the three groups are shown in Table 1 . None of the patients with MVD who had NSR nor any of the control patients had a documented history of AF. Patient number 6 in the MVD ϩ AF group had a VVI type pacemaker (Medtronic Inc., Minneapolis, Minnesota) for one year before the operation. The values for left ventricular ejection fraction were within the normal range in all three groups. Although right atrial pressure (RAP) tended to be higher in patients with MVD who had AF than they were in patients with MVD who had NSR or in control patients, there was no statistically significant difference among the groups. However, pulmonary capillary wedge pressure (PCWP) and left atrial diameter (LAD) were both larger in patients with MVD who had either AF or NSR than they were in control patients. In patients with MVD who had AF, LAD was significantly larger than in patients with MVD who had NSR. Analysis of IP3 receptor expression by the Western blot method. Figure 1 shows the expression level of the IP3 receptor protein in right atrial tissue from patients with MVD who had either AF or NSR and from control patients. The level was significantly higher in patients with MVD who had AF (0.75 Ϯ 0.26) than it was in patients with MVD who had NSR (0.42 Ϯ 0.13), and both values were significantly higher than that obtained for the control group (0.14 Ϯ 0.08). In patients with mitral valvular disease (MVD) who have AF, the expression level was significantly higher than that found in patients with MVD who had NSR. In both groups of patients with MVD (who had AF or NSR), the expression level was also significantly greater than it was in the control group. Data are mean Ϯ SD.
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Next, the data for the expression level of IP3 receptor protein in the right atrium were pooled for all 26 patients and broken down according to the patient's LAD, PCWP or RAP. As shown in Figure 2 : i) the relative expression level was 0.66 Ϯ 0.28 in those patients with a larger LAD (Ն40 mm) and 0.14 Ϯ 0.08 in the those with a smaller LAD (Ͻ40 mm), and there was a significant difference between these two groups. For PCWP (ii in Fig. 2) , the relative expression level was 0.73 Ϯ 0.26 in those with a higher PCWP (Ն10 mm Hg) and 0.23 Ϯ 0.16 in those with a lower PCWP (Ͻ10 mm Hg), the difference being significant. The relative expression level of IP3 receptor protein in patients with a higher RAP (Ն5 mm Hg) (0.67 Ϯ 0.35) was greater than it was in those with a lower RAP (Ͻ5 mm Hg) (0.32 Ϯ 0.21) (iii in Fig. 2) . Analysis of expression levels of the mRNA for the IP3 receptor. We next examined the expression levels of the mRNAs encoding the IP3 receptor using total RNA extracted from the patient's atrial tissues. Figure 3 shows these levels for patients with MVD who had AF or NSR and for control patients. The expression level was significantly higher in homogenates prepared from the right atrium of patients with MVD who had AF (0.028 Ϯ 0.008) than it was in those from the right atrium of control patients (0.015 Ϯ 0.004). There was no significant difference in this expression level between patients with MVD who had AF and patients with MVD who had NSR (0.020 Ϯ 0.006).
When data from all 26 patients (patients with MVD who had AF or NSR and controls) were analyzed together, a positive correlation (r ϭ 0.681) was found between the expression level of IP3 receptor protein and that of its mRNA (Fig. 4) .
Next, the data for the expression levels of IP3 receptor mRNA in the right atrium were pooled for all 26 patients and broken down according to the patient's LAD, PCWP ) and that there was a significant difference between these two groups. For PCWP (ii in Fig. 5 ), the corresponding values were 0.025 Ϯ 0.006 in those with a higher PCWP (Ն10 mm Hg) and 0.018 Ϯ 0.007 in those with a lower PCWP (Ͻ10 mm Hg), the difference being significant. The relative expression level tended to be greater in those with a higher RAP (Ն5 mm Hg) (0.024 Ϯ 0.008) than it was in those with a lower RAP (Ͻ5 mm Hg) (0.020 Ϯ 0.007), but the difference did not reach significance (iii in Fig. 5 ).
Immunohistochemistry by light microscopy. Figure 6 shows the immunolocalization of the IP3 receptor at the light microscopic level in right atrial tissues from representative patients. Immunoreactivity for the IP3 receptor was found both within the cytosol and at the nuclear envelope of cardiac myocytes. In patients with MVD, IP3 receptor expression was greater than it was in the control both in the cytosol and at the nuclear envelope. 
DISCUSSION
The main findings of this study were twofold. First, in patients with chronic AF due to MVD, there were significant increases in the expression levels of IP3 receptor protein and mRNA in the right atrium, and the expression of the IP3 receptor was increased (compared with that of patients in the control group) both in the cytosol and at the nuclear envelope of atrial myocytes. Second, in all patients:
1) there was a significant positive correlation between the expression levels of IP3 receptor protein and its mRNA, and 2) the expression levels of IP3 receptor protein and mRNA in the right atrium were greater at higher levels of left atrial dimension or PCWP (although these expression levels were not significantly affected by the level of RAP). To our knowledge, although some investigators (6, 14, 15) have suggested that changes in IP3/Ca 2ϩ signaling may be important in cardiac arrhythmogenesis, this is the first investigation in which an up-regulation of IP3 receptor protein and mRNA levels have been detected in the atrium of patients with chronic AF as compared with patients with NSR. In contrast, other Ca 2ϩ regulatory proteins (RyR) are down-regulated (2). The alterations we have detected in RyR (2) and IP3 receptors might result in the establishment of an abnormal cytoplasmic Ca 2ϩ concentration and, as a consequence, initiate or perpetuate changes in the electrophysiologic properties of atrial tissue that, in turn, initiate or perpetuate AF. Up-regulation of IP3 receptor in patients with MVD who have chronic AF. In addition to the RyR, a second type of Ca 2ϩ release channel, the IP3 receptor, was identified on the endoplasmic reticulum of rodent brain and smooth muscle cells (16, 17) . A few years later, the IP3 receptor expressed in cardiac myocytes was found to be structurally very similar to the type 1 IP3 receptor expressed in vascular smooth muscle and the cerebellum (4). The dominant mechanism underlying excitation-contraction coupling in cardiac muscle is Ca 2ϩ -induced Ca 2ϩ release via the RyR (14, 18) , and the properties of the IP3 receptor seem to be quite different from those of the Ca 2ϩ gated Ca 2ϩ release channel (RyR). Go et al. (15) showed that RyR and IP3 receptors were regulated in opposite directions in failing human hearts, the RyR mRNA levels being decreased while the IP3 receptor mRNA levels were increased. Recently, we reported a decrease in SR Ca 2ϩ release function, as well as a decrease in the number of RyR, during the development of volume-overloaded heart failure (19), and we also showed that there were significant decreases in the number of RyR and the expression level of RyR mRNA in patients with chronic AF due to MVD (2) . The important finding of our studies is that not only is there this down-regulation of RyR receptor protein and mRNA levels in patients with chronic AF due to MVD, but there is also an increase in the expression of the IP3 receptor. These results are consistent with the observations of Go et al. (15) on the failing human myocardium (see preceding text). Possibly, mechanical overload of the atrial myocardium might initially cause a down-regulation of RyR, and the alternative pathway for the regulation of intracellular Ca 2ϩ (via the IP3 receptor Ca 2ϩ release channel) might then undergo an up-regulation and, thus, serve as a significant compensatory mechanism.
Interestingly, in the patients with MVD examined in this study, an increased immunoreactivity for the IP3 receptor was found at the nuclear envelope as well as in intracellular Figure 6 . Immunostaining for inositol 1,4,5 trisphosphate receptor (IP3 receptor) protein in the atrial myocardium. In a control patient (A), immunoreactivity for IP3R protein was found within the cytosol and at the nuclear envelope of myocytes. In patients with mitral valvular disease with either normal sinus rhythm (B) or atrial fibrillation (C), the expression was increased both in the cytosol and at the nuclear envelope.
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Yamada et al. March 15, 2001 March 15, :1111 IP3 Receptors in the Chronically Fibrillating Atrium membranes. In fact, Humbert et al. (20) previously reported the existence of the IP3 receptor at the nuclear membrane, and IP3 has been shown to trigger an increase in nucleoplasmic Ca 2ϩ (21, 22) . Ca 2ϩ has been shown to be involved in the regulation of such typical nuclear functions as gene expression and DNA breakdown, repair and replication (23) . In patients with MVD, mechanical overload of the myocardium might cause an over-expression of IP3 receptors in the nuclear envelope as a way of controlling the nucleoplasmic Ca 2ϩ concentration (thus regulating cellular biological functions, metabolism or hypertrophic reactions). If so, intracellular Ca 2ϩ release, via the IP3 receptor, might be a critical step in the control of cellular metabolism in such patients. Up-regulation of the IP3 receptor and its possible relation to the mechanisms causing chronic AF. In addition to regulating contractility and facilitating cellular metabolism in the diseased myocardium, the IP3/Ca 2ϩ signaling pathway may play a pathological role in cardiac arrhythmogenesis (14) . Gorza et al. (24) suggested that Ca 2ϩ release via IP3 receptors may be causally related both to an increase in automaticity and the generation of some arrhythmias. They also reported an increased accumulation of IP3 receptor mRNA in atrial myocytes in the senescent heart, and they speculated that an increased expression of IP3 receptors in cardiac myocytes might play a pivotal role in the regulation of chronotropism (24) . In cardiac muscle, the development of a high myoplastic Ca 2ϩ level during diastole (Ͼ 500 nM) due to intracellular Ca 2ϩ oscillations appears to induce an abnormal transient inward current (25, 26) . Further, data from skinned cardiac cells suggest that IP3 may only play a pathological role in cardiac arrhythmogenesis by enhancing spontaneous Ca 2ϩ oscillations (27) . In our study, the expression levels of IP3 receptor protein and its mRNA were increased in the right atrium of patients with MVD (perhaps by way of compensation for down-regulation of the RyR receptor), and, moreover, these expression levels were higher in patients with MVD who had AF than they were in patients with MVD who had NSR. Conceivably, the increased IP3 receptor expression in the atrium of patients with MVD may be causally related to the tendency for AF to be initiated or perpetuated in such patients.
It is well known that most tachyarrythmias begin with an early premature beat. After the wave front spreads from the premature site, the spatially inhomogeneous properties of the cellular network alter the excitation wave sufficiently to create an asymmetry of conduction, and circus movement reentry ensues (28) . Recent electrophysiologic and clinical evidence suggests an expanded picture that points to an adaptive structural mechanism-the distribution of gap junctions associated with the development of microfibrosis (28)-as the major cause of most forms of AF. Moreover, a disturbance of side-to-side electrical coupling between cells (nonuniform anisotropy) is thought to play a central role in the genesis of AF (29 via a positive-feedback process (whereby Ca 2ϩ stimulates its own release through the IP3 receptor). The sequential movement of IP3 through ever more distal cells results in a corresponding intercellular Ca 2ϩ wave. Interestingly, the IP3 receptor has been reported to be present in ventricular and atrial myocytes and localized to the region of the gap junction, and the gap junction serves an important role in intercellular electrical coupling so that heart muscle is electrically synchronized (5) . In our study we looked for evidence of an abnormal expression of IP3 receptors in the gap junction area, but we could find no such evidence. However, if others or we can find an abnormal dispersion of IP3 receptors around gap junctions in patients with AF, it will be suggestive evidence linking IP3 receptor upregulation causally with the conduction disturbances that initiate or perpetuate reentrant arrhythmias. Study limitations. In our study, we enrolled as control patients with ischemic heart disease, but with NSR. However, they were not completely "normal," and their right atrium might have been affected. Nevertheless, the hemodynamic data obtained by reviewing the results of preoperative cardiac catheterization and echocardiography were normal, and these control patients did not exhibit signs of right atrial overload.
An additional limitation was that we could not perform detailed histopathological and electrophysiological examinations of right atrial tissues because of the difficulty of performing studies on human tissues, and the size of the myocardial tissue sample that could be obtained from the patients during surgery was critically limited. We have speculated that the increase of IP3 receptors may cause changes in cellular excitability, but we did not directly show the evidence that the increase of IP3 receptors has "functional" consequences on cardiac electrophysiology. Clearly, an examination of electrophysiology in human atrial myocytes from patients with chronic AF would be of great interest. Although we could not carry out an electrophysiolgical study on small samples, the changes of SR Ca 2ϩ regulatory proteins could, at least in part, contribute to the maintenance of AF. Conclusions. Several investigators have discussed intracellular Ca 2ϩ abnormality as a possible initiator or perpetuator of AF. However, there has been a lack of direct evidence of abnormalities in the modulators of intracellular Ca 2ϩ homeostasis. In this study, we report that chronic mechanical overload of the atrial myocardium is associated with an increase in the expression level of the IP3 receptor and that this level was greater in patients with chronic AF. These results suggest that, in patients with chronic AF, upregulation of IP3 receptors may be important in modulating
